ALASTAIR THOMPSON to Proportional Hazards Models
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Proportional Hazards Models.
Connection Strength
0.114
-
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
Score: 0.051
-
Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up. Br J Cancer. 1998 Mar; 77(5):797-800.
Score: 0.021
-
Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer. 2014 Jul 29; 111(3):623-7.
Score: 0.017
-
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ. 2012 Jul 13; 345:e4447.
Score: 0.014
-
A candidate molecular signature associated with tamoxifen failure in primary breast cancer. Breast Cancer Res. 2008; 10(5):R88.
Score: 0.011